Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

A new reverse genetics system for norovirus could aid in the development of novel antiviral therapies and vaccines.

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

Rising demand for monoclonal antibodies, recombinant proteins, and gene therapies accelerates outsourcing to specialized CROs and CDMOs worldwide.Austin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- As per SNS ...

Every December, I review the past 12 months and write about the things I learned. When I began writing this column 15 years ...

According to doctors, the discovery of the strain is "precisely what experts in the field feared would happen" ...

A hybrid form of mpox has been identified in the UK. Health professionals are not surprised that the sexually transmitted ...

Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.

Researchers from The University of Osaka have developed a novel reverse genetics system to study norovirus, the leading cause of gastroenteritis. This efficient system can generate infectious viral ...

UKHSA confirms a new mpox strain in England. Learn the symptoms, signs and risks as experts assess whether the recombinant ...

Detailed price information for Kraig Biocraft Laboratories Inc (KBLB) from The Globe and Mail including charting and trades.

On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to ...